Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00515294 · ClinicalTrials.gov registry record · Phase 1
Acute and Residual Effects of Caffeinated Beer
A Phase 1 study of Alcohol Intoxication and Neurobehavioral Manifestations, sponsored by Boston University.
- Completed
- Registry status
- Phase 1
- Development phase
- 154
- Enrollment target
- 1
- Study location
NCT00515294 is a Phase 1 study of Alcohol Intoxication and Neurobehavioral Manifestations that has completed, run by Boston University. The registered enrollment target is 154 participants, below the 337-participant average among 15 other Alcohol Intoxication trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00515294, a Phase 1 study of Alcohol Intoxication and Neurobehavioral Manifestations, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 154 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to develop information about the acute and residual effects of a new product being targeted to young adults. Using a double placebo-controlled 2 X 2 factorial model study design, we will compare the acute and residual effects on driving impairment of caffeinated alcohol, non-caffeinated alcohol, caffeinated placebo, and non-caffeinated placebo. Under the alcohol conditions, participants will receive sufficient alcoholic beverage to attain a blood alcohol concentration (BAC) of .12 g%. Participants will be 144 undergraduate and graduate students, and recent college graduates.
Conditions Studied
Interventions
- DRUG Caffeinated Alcoholic Beer
- OTHER Non-Caffeinated Alcoholic Beer
- DRUG Caffeinated Non-Alcoholic Beer
- OTHER Non-Caffeinated, Non-Alcoholic Beer
Study Locations (1)
Massachusetts
- General Clinical Research Center, Boston Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2006-10 |
| Est. Completion | 2009-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00515294
The ClinicalTrials.gov registry entry for NCT00515294 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 337-participant average among 15 other Alcohol Intoxication trials with a reported enrollment target (54% lower). The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Alcohol Intoxication appearing as the primary indexed condition, and to 4 interventions - of which Caffeinated Alcoholic Beer is the first listed.
NCT00515294 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00515294 about?
NCT00515294 is a clinical study titled "Acute and Residual Effects of Caffeinated Beer". The aim of this study is to develop information about the acute and residual effects of a new product being targeted to young adults. Using a double placebo-controlled 2 X 2 factorial model study design, we will compare the acute and residual effects on driving impairment of caffeinated alcohol, non...
What is the current status of trial NCT00515294?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 154 participants. The study started on 2006-10. Estimated completion is 2009-10.
What conditions does trial NCT00515294 study?
This clinical trial studies the following conditions: Alcohol Intoxication, Neurobehavioral Manifestations, Drug Related Sleep Disturbance.
What interventions are being tested in trial NCT00515294?
The interventions under investigation include: Caffeinated Alcoholic Beer (DRUG), Non-Caffeinated Alcoholic Beer (OTHER), Caffeinated Non-Alcoholic Beer (DRUG), Non-Caffeinated, Non-Alcoholic Beer (OTHER).
Who is sponsoring clinical trial NCT00515294?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00515294 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Intoxication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment
RECRUITING · Phase 1
-
The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment
COMPLETED · Phase 1
-
Suicide Intervention for Alaska Native Youth
RECRUITING · NA
-
Alcohol and the Social Brain: an Alcohol-Administration Hyperscanning Study
RECRUITING
-
Alcohol and Sexual Communication Among Couples in the Laboratory
RECRUITING · NA
-
Effect of Nutritional Ketosis on Alcohol Metabolism
RECRUITING · Phase 2
Explore more on PlainTrial
Alcohol Intoxication
All registered trials for this condition
Neurobehavioral Manifestations
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.